358 related articles for article (PubMed ID: 10611071)
1. Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium.
Zhang J; Hampton AL; Nie G; Salamonsen LA
Biol Reprod; 2000 Jan; 62(1):85-94. PubMed ID: 10611071
[TBL] [Abstract][Full Text] [Related]
2. Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1 -MMP) compartment of proMMP-2 activation in MG-63 cells.
Luo XH; Liao EY
Horm Metab Res; 2001 Jul; 33(7):383-8. PubMed ID: 11507673
[TBL] [Abstract][Full Text] [Related]
3. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
[TBL] [Abstract][Full Text] [Related]
4. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.
Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A
Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137
[TBL] [Abstract][Full Text] [Related]
5. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration.
Gaide Chevronnay HP; Selvais C; Emonard H; Galant C; Marbaix E; Henriet P
Biochim Biophys Acta; 2012 Jan; 1824(1):146-56. PubMed ID: 21982799
[TBL] [Abstract][Full Text] [Related]
6. Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy.
Noda K; Ishida S; Inoue M; Obata K; Oguchi Y; Okada Y; Ikeda E
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2163-70. PubMed ID: 12714657
[TBL] [Abstract][Full Text] [Related]
7. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
[TBL] [Abstract][Full Text] [Related]
8. Rapid activation of matrix metalloproteinase-2 by glioma cells occurs through a posttranslational MT1-MMP-dependent mechanism.
Gingras D; Pagé M; Annabi B; Béliveau R
Biochim Biophys Acta; 2000 Sep; 1497(3):341-50. PubMed ID: 10996658
[TBL] [Abstract][Full Text] [Related]
9. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding.
Galant C; Berlière M; Dubois D; Verougstraete JC; Charles A; Lemoine P; Kokorine I; Eeckhout Y; Courtoy PJ; Marbaix E
Am J Pathol; 2004 Jul; 165(1):83-94. PubMed ID: 15215164
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium.
Chung HW; Lee JY; Moon HS; Hur SE; Park MH; Wen Y; Polan ML
Fertil Steril; 2002 Oct; 78(4):787-95. PubMed ID: 12372458
[TBL] [Abstract][Full Text] [Related]
11. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y
Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907
[TBL] [Abstract][Full Text] [Related]
13. Mast cell regulation of human endometrial matrix metalloproteinases: A mechanism underlying menstruation.
Zhang J; Nie G; Jian W; Woolley DE; Salamonsen LA
Biol Reprod; 1998 Sep; 59(3):693-703. PubMed ID: 9716571
[TBL] [Abstract][Full Text] [Related]
14. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
15. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
Monea S; Lehti K; Keski-Oja J; Mignatti P
J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722
[TBL] [Abstract][Full Text] [Related]
16. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers.
Théret N; Musso O; L'Helgoualc'h A; Campion JP; Clément B
Am J Pathol; 1998 Sep; 153(3):945-54. PubMed ID: 9736043
[TBL] [Abstract][Full Text] [Related]
17. Regulation of matrix metalloproteinase-9/gelatinase B expression and activation by ovarian steroids and LEFTY-A/endometrial bleeding-associated factor in the human endometrium.
Cornet PB; Galant C; Eeckhout Y; Courtoy PJ; Marbaix E; Henriet P
J Clin Endocrinol Metab; 2005 Feb; 90(2):1001-11. PubMed ID: 15536155
[TBL] [Abstract][Full Text] [Related]
18. Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation.
Määttä M; Soini Y; Liakka A; Autio-Harmainen H
Am J Clin Pathol; 2000 Sep; 114(3):402-11. PubMed ID: 10989641
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma.
Isaka K; Nishi H; Nakai H; Nakada T; Feng Li Y; Ebihara Y; Takayama M
Cancer; 2003 Jan; 97(1):79-89. PubMed ID: 12491508
[TBL] [Abstract][Full Text] [Related]
20. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
Ottino P; He J; Axelrad TW; Bazan HE
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):487-96. PubMed ID: 15671273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
